| 12466849 |
Anti-viral and anti-tumoral compounds |
Helena Shomar Monges, Rotem Sorek, Lianet Noda Garcia, Arthur Machlenkin |
2025-11-11 |
|
| 12312345 |
Fluoroalkyl-oxadiazoles and uses thereof |
Snahel Patel, Mohammad A. MANDEGAR, Pingyu Ding, Ulhas Bhatt, Martin HOLAN +6 more |
2025-05-27 |
|
| 12049439 |
Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives |
Julie Farand, Joshua A. Kaplan, Gregory Notte, Casey Lockwood Olen, Michael Sangi |
2024-07-30 |
|
| 11945785 |
Pyrazine compounds as inhibitors of FLT3 |
Xiaodong Wang, Thorsten A. Kirschberg, James T. Palmer, Thomas Butler, Solomon Ungashe +6 more |
2024-04-02 |
$11,350,000 |
| 11926622 |
Fluoroalkyl-oxadiazoles and uses thereof |
Snahel Patel, Mohammad A. MANDEGAR, Julio C. Medina, Ulhas Bhatt, Alok Nerurkar +1 more |
2024-03-12 |
$9,317,000 |
| 11578066 |
Fluoroalkyl-oxadiazoles and uses thereof |
Snahel Patel, Mohammad A. MANDEGAR, Julio C. Medina, Ulhas Bhatt, Alok Nerurkar +1 more |
2023-02-14 |
$4,312,000 |
| 11352316 |
Opioid receptor modulators and products and methods related thereto |
Julio C. Medina, Lawrence R. McGee, Zhi-Liang Wei, Corinne Sadlowski, Frederick Seidl +7 more |
2022-06-07 |
|
| 11179397 |
Imidazopyrimidine derivatives |
Gregory Chin, Michael O' Neil Hanrahan Clarke, Xiaochun Han, Tim Hansen, Yunfeng Eric Hu +6 more |
2021-11-23 |
$216,502,000 |
| 11136290 |
Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives |
Julie Farand, Joshua A. Kaplan, Gregory Notte, Casey Lockwood Olen, Michael Sangi |
2021-10-05 |
|
| 10174038 |
Compounds and methods for antiviral treatment |
Hon Chung Hui, Jay P. Parrish, Michael Sangi, Dustin Siegel, Hai Yang |
2019-01-08 |
$217,992,000 |
| 10017501 |
Benzimidazole derivatives as bromodomain inhibitors |
Evangelos Aktoudianakis, Gregory Chin, Britton Kenneth Corkey, Jinfa Du, Kristyna M. Elbel +10 more |
2018-07-10 |
$525,460,000 |
| 9957275 |
Pyrazolo[1,5-A]pyrimidines for antiviral treatment |
Kerim Babaoglu, Constantine G. Boojamra, Eugene J. Eisenberg, Hon Chung Hui, Richard L. Mackman +5 more |
2018-05-01 |
$363,238,000 |
| 9951065 |
Benzimidazole and imadazopyridine carboximidamide compounds |
Mark J. Bartlett, Julian A. Codelli, Britton Kenneth Corkey, Jennifer L. Cosman, Kristyna M. Elbel +4 more |
2018-04-24 |
$155,957,000 |
| 9504689 |
Compounds and methods for antiviral treatment |
Dustin Siegel, Hai Yang, Michael Sangi, Jay P. Parrish, Hon Chung Hui |
2016-11-29 |
$181,866,000 |
| 9458145 |
Benzimidazole derivatives as bromodomain inhibitors |
Evangelos Aktoudianakis, Gregory Chin, Britton Kenneth Corkey, Jinfa Du, Kristyna M. Elbel +10 more |
2016-10-04 |
$144,218,000 |
| 9255089 |
Benzimidazolone derivatives as bromodomain inhibitors |
Evangelos Aktoudianakis, Gregory Chin, Britton Kenneth Corkey, Jinfa Du, Kristyna M. Elbel +8 more |
2016-02-09 |
$342,012,000 |
| 9238039 |
Pyrazolo[1,5-A]pyrimidines for antiviral treatment |
Kerim Babaoglu, Constantine G. Boojamra, Eugene J. Eisenberg, Hon Chung Hui, Richard L. Mackman +5 more |
2016-01-19 |
$613,553,000 |
| 9108953 |
Quinoline derivatives as bromodomain inhibitors |
Kerim Babaoglu, Britton Kenneth Corkey, Robert Jiang, Hai Yang |
2015-08-18 |
$1,129,469,000 |
| 8999969 |
Anti-RSV compounds |
Richard L. Mackman, Hai Yang |
2015-04-07 |
$530,723,000 |
| 8980878 |
Compounds and methods for antiviral treatment |
Dustin Siegel, Hai Yang, Michael Sangi, Jay P. Parrish, Hon Chung Hui |
2015-03-17 |
$534,621,000 |
| 8946238 |
Pyrazolo[1,5-A]pyrimidines as antiviral agents |
Constantine G. Boojamra, Hon Chung Hui, Petr Jansa, Richard L. Mackman, Jay P. Parrish +3 more |
2015-02-03 |
$1,001,938,000 |
| 8809330 |
Pyrazolo[1,5-A]pyrimidines for antiviral treatment |
Kerim Babaoglu, Constantine G. Boojamra, Eugene J. Eisenberg, Hon Chung Hui, Richard L. Mackman +5 more |
2014-08-19 |
$228,809,000 |
| 8486938 |
Pyrazolo[1,5-a]pyrimidines for antiviral treatment |
Kerim Babaoglu, Constantine G. Boojamra, Eugene J. Eisenberg, Hon Chung Hui, Richard L. Mackman +5 more |
2013-07-16 |
$295,019,000 |
| 8324179 |
Nucleoside analogs for antiviral treatment |
James M. Chen, Alan X. Huang, Richard L. Mackman, Jay P. Parrish, Jason K. Perry +1 more |
2012-12-04 |
$148,543,000 |
| 6861419 |
Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof |
John Drewe, Sui Xiong Cai, Emma Shelton, Joane Litvak, Jeffrey R. Spencer +1 more |
2005-03-01 |
$9,475,000 |